Search research articles
Contact Us
Filters
Showing results (21-30 of 40) with videos related to
Page
of 4
Sort By:
Scientific Reports
|
July 15, 2025
MTAP deficiency is highly homogeneous in advanced, muscle-invasive urothelial carcinoma of the urinary bladder
Natalia Gorbokon, Katharina Teljuk, Viktor Reiswich, et al.
International Urology and Nephrology
|
December 16, 2024
PLAP expression is linked to invasive tumor growth in urothelial carcinoma of the bladder
Henning Plage, Kira Furlano, Sebastian Hofbauer, et al.
BMC Urology
|
February 20, 2025
GATA3 amplification is associated with high grade disease in non-invasive urothelial bladder cancer but unrelated to patient prognosis
Henning Plage, Adrian Frericks, Sebastian Hofbauer, et al.
Cancers
|
December 30, 2025
Differential Androgen Receptor Expression Across Bladder Cancer Stages and Its Link to Poor Outcomes
Henning Plage, Nadine Biernath, Kira Furlano, et al.
Neoplasia (New York, N.Y.)
|
June 24, 2025
Prognostic role of high MTAP expression is reversed by the ERG status in prostate cancer treated by radical prostatectomy
Natalia Gorbokon, Seyma Büyücek, Henning Plage, et al.
Human Pathology
|
September 24, 2022
GATA3 expression loss is linked to stage progression but is unrelated to prognosis in muscle-invasive urothelial carcinoma of the bladder
Henning Plage, Henrik Samtleben, Sebastian Hofbauer, et al.
Acta Oncologica (Stockholm, Sweden)
|
November 8, 2023
Altered p53/p16 expression is linked to urothelial carcinoma progression but largely unrelated to prognosis in muscle-invasive tumors
Simon Schallenberg, Henning Plage, Sebastian Hofbauer, et al.
Frontiers in Oncology
|
May 20, 2026
Glutathione peroxidase 2 expression in human tumors: a tissue microarray study on 18,555 tumors
Viktoria Chirico, Niklas Jahn, Seyma Büyücek, et al.
Experimental and Molecular Pathology
|
March 30, 2023
Cytokeratin 20 expression is linked to stage progression and to poor prognosis in advanced (pT4) urothelial carcinoma of the bladder
Paul Giacomo Bruch, Henning Plage, Sebastian Hofbauer, et al.
Genes, Chromosomes & Cancer
|
September 26, 2024
17p13 (TP53) Deletions Are Associated With an Aggressive Phenotype but Unrelated to Patient Prognosis in Urothelial Bladder Carcinomas
Martina Kluth, Melanie Hitzschke, Kira Furlano, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 40) with videos related to
Sort By:
Page
of 4
Scientific Reports
|
July 15, 2025
MTAP deficiency is highly homogeneous in advanced, muscle-invasive urothelial carcinoma of the urinary bladder
Natalia Gorbokon, Katharina Teljuk, Viktor Reiswich, et al.
International Urology and Nephrology
|
December 16, 2024
PLAP expression is linked to invasive tumor growth in urothelial carcinoma of the bladder
Henning Plage, Kira Furlano, Sebastian Hofbauer, et al.
BMC Urology
|
February 20, 2025
GATA3 amplification is associated with high grade disease in non-invasive urothelial bladder cancer but unrelated to patient prognosis
Henning Plage, Adrian Frericks, Sebastian Hofbauer, et al.
Cancers
|
December 30, 2025
Differential Androgen Receptor Expression Across Bladder Cancer Stages and Its Link to Poor Outcomes
Henning Plage, Nadine Biernath, Kira Furlano, et al.
Neoplasia (New York, N.Y.)
|
June 24, 2025
Prognostic role of high MTAP expression is reversed by the ERG status in prostate cancer treated by radical prostatectomy
Natalia Gorbokon, Seyma Büyücek, Henning Plage, et al.
Human Pathology
|
September 24, 2022
GATA3 expression loss is linked to stage progression but is unrelated to prognosis in muscle-invasive urothelial carcinoma of the bladder
Henning Plage, Henrik Samtleben, Sebastian Hofbauer, et al.
Acta Oncologica (Stockholm, Sweden)
|
November 8, 2023
Altered p53/p16 expression is linked to urothelial carcinoma progression but largely unrelated to prognosis in muscle-invasive tumors
Simon Schallenberg, Henning Plage, Sebastian Hofbauer, et al.
Frontiers in Oncology
|
May 20, 2026
Glutathione peroxidase 2 expression in human tumors: a tissue microarray study on 18,555 tumors
Viktoria Chirico, Niklas Jahn, Seyma Büyücek, et al.
Experimental and Molecular Pathology
|
March 30, 2023
Cytokeratin 20 expression is linked to stage progression and to poor prognosis in advanced (pT4) urothelial carcinoma of the bladder
Paul Giacomo Bruch, Henning Plage, Sebastian Hofbauer, et al.
Genes, Chromosomes & Cancer
|
September 26, 2024
17p13 (TP53) Deletions Are Associated With an Aggressive Phenotype but Unrelated to Patient Prognosis in Urothelial Bladder Carcinomas
Martina Kluth, Melanie Hitzschke, Kira Furlano, et al.
Page
of 4